The frequency of FZD1/2/3/4/5/7/8/10 gene amplification in primary prostate cancer is also relatively low (≤3%), with incidence increasing slightly in metastatic disease (≤4.5%) (Tables S1–S4). This evidence concerns the gene FZD1 and Familial prostate cancer.